Galectin-3 predicts cardiovascular events in patients with type-2 diabetes - Lorenzo-Almoros, A; Pello, A; Acena, A; Martinez-Milla, J; Tarin, N; Cristobal, C; Blanco-Colio, L M; Martin-Ventura, J L; Huelmos, A; Gutierrez-Landaluce, C; Lopez-Castillo, M; Alonso, J; et al. (European Heart Journal, 2020)